Characteristics | Unrealistic pessimistic RP patients, N = 32 | Unrealistic optimistic RP patients, N = 24 | p |
---|---|---|---|
Socio-demographic | |||
Female sex1 | 31 (96.9) | 24 (100) | 1 |
Years of age | 59.5 (49.6–64.6) | 57.1 (43.3–61.7) | 0.329 |
Years of formal education | 9 (6–15.8) | 9 (6–12) | 0.590 |
Medium-low SE level1 | 29 (90.6) | 24 (100) | 0.252 |
RA-related | |||
Serum positive RF1 | 24 (75) | 24 (100) | 0.008 |
Serum positive ACCP1 | 25 (78.1) | 24 (100) | 0.016 |
Years of disease duration | 13.5 (8.7–18) | 18.5 (7.4–25) | 0.329 |
Rheumatoid nodes1 | 15 (46.9) | 13 (54.2) | 0.787 |
RAPID-3 | 4.1 (1.4–12.6) | 15.3 (14.1–18.7) | 0.002 |
High disease activity category1 | 6 (18.8) | 19 (79.2) | ≤ 0.0001 |
Patient-reported outcomes | |||
Pain-VAS | 8 (3.3–14) | 27.5 (7.6–36) | 0.007 |
Overall disease-VAS | 7.5 (2–15) | 32.5 (7.5–45.8) | 0.001 |
HAQ score | 0.25 (0–1.1) | 2 (1.4–2.5) | ≤ 0.0001 |
SF-36 score | 77.2 (55.4–87.3) | 42.5 (22.6–67) | ≤ 0.0001 |
Mental component score (SF-36) | 71.9 (56.5–87.8) | 48.1 (32–67) | 0.002 |
Physical component score (SF-36) | 74 (48.9–84.6) | 39.7 (17.4–53.3) | ≤ 0.0001 |
Comorbidity | |||
Presence of comorbidity1 | 19 (59.4) | 19 (79.2) | 0.153 |
Surgical joint replacement1 | 9 (28.1) | 13 (54.2) | 0.059 |
Treatment | |||
DMARDs/patient | 1 (1–2) | 2 (1–2) | 0.165 |
Corticosteroids use1 | 11 (34.4) | 18 (75) | 0.003 |
Intensive treatment1 | 10 (31.3) | 18 (75) | 0.003 |
Compliance with treatment | |||
Adherence1 | 18 (56.3) | 11 (45.8) | 0.590 |
Persistence1 | 19 (59.4) | 111 (45.8) | 0.418 |
Concordance1 | 15 (46.9) | 10 (41.7) | 0.789 |
Miscellaneous | |||
Health Literacy1 | 24 (75) | 22 (91.7) | 0.162 |
Adequate RA knowledge1 (based on CQ) | 25 (44.6) | 170 (47.4) | 0.774 |
RA family history1 | 18 (56.3) | 10 (41.7) | 0.418 |
Significant RP1 | 32 (100) | 0 | ≤ 0.0001 |
Unfavorable medical criteria | 5 (5–6) | 7.5 (7–8) | ≤ 0.0001 |